Submitted by don on Wed, 09/10/2025 - 18:08
monoclonal

Looking to streamline your antibody research? LAMPIRE delivers affordable, high-quality hybridoma development tailored to your scientific needs. Every project begins with a FREE Antigen Design consultation and Project Scope Meetings, led by our technical experts.

We guide you through a three-phase process:

Phase I – Design & Immunization: includes ELISA titer monitoring

Phase II – Cell Fusion & Screening: approval checkpoints along the way

Phase III – Cloning & Expansion: expanding and cryopreserving cell lines with >95% stability

Get efficient, reliable, and tailored hybridoma solutions with LAMPIRE.

Attachments